APA (7th ed.) Citation

P, Z., A, W., A, S., A, K., A, K., K, W., . . . G, H. (2026). Pre-transplant JAK-inhibition improves post-transplant outcome in myelofibrosis. Clinical and experimental medicine, 26(1), . https://doi.org/10.1007/s10238-026-02153-z

Chicago Style (17th ed.) Citation

P, Zielińska, Wieczorkiewicz-Kabut A, Spałek A, Kopińska A, Koclęga A, Woźniczka K, Boral K, Butrym A, and Helbig G. "Pre-transplant JAK-inhibition Improves Post-transplant Outcome in Myelofibrosis." Clinical and Experimental Medicine 26, no. 1 (2026). https://doi.org/10.1007/s10238-026-02153-z.

MLA (9th ed.) Citation

P, Zielińska, et al. "Pre-transplant JAK-inhibition Improves Post-transplant Outcome in Myelofibrosis." Clinical and Experimental Medicine, vol. 26, no. 1, 2026, https://doi.org/10.1007/s10238-026-02153-z.